Two kinds of announcement, and why only one is cited here

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
A topline press release states headline results selected by the sponsor, without the full data, methods or statistical detail. A peer-reviewed publication presents the complete analysis, reviewed by independent experts before acceptance. The two can describe the same trial and support different degrees of confidence, which is why this site cites publications.

What a press release contains

Typically the primary endpoint result, selected secondary results, a summary of safety and a statement about next steps. It is written by the sponsor, is not reviewed externally, and omits the detail — baseline characteristics, dropout, subgroup results, confidence intervals — needed to assess the claim.

It is accurate as far as it goes and it is not evidence in the sense a paper is.

What peer review adds

Independent reviewers examine the methods, the analysis and the conclusions before a journal accepts the paper. The published version includes the full results, the pre-registered endpoints, and the authors' own statement of limitations. Discrepancies between the release and the paper, when they occur, are visible only once the paper exists.

The retatrutide phase 2 results exist in both forms; the pages on this site describe the papers.

How this applies to phase 3

TRIUMPH trial results have been and will be announced as toplines before publication. Until a peer-reviewed paper is available, this site describes the programme and does not report the numbers, because a figure from a press release cannot be checked against methods that have not been published.

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What a press release contains?

Typically the primary endpoint result, selected secondary results, a summary of safety and a statement about next steps. It is written by the sponsor, is not reviewed externally, and omits the detail — baseline characteristics, dropout, subgroup results, confidence intervals — needed to assess the claim.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.